1. What Is the Blood Gas Analysis Market?
The Blood Gas Analysis Market covers the point-of-care and central laboratory analysers that measure the arterial blood gas parameters. The parameters include pH, partial pressure of oxygen and carbon dioxide, bicarbonate, base excess, and oxygen saturation alongside the electrolytes, metabolites, and co-oximetry parameters. The critically ill patients require these for the respiratory management, acid-base status monitoring, and metabolic assessment that intensive care medicine and emergency medicine demand at the point of care. Blood gas analysers operate on microlitre whole blood samples using the electrochemical sensors, optical sensors, and co-oximetry spectrometry. The sensors measure pH, pCO2, pO2, sodium, potassium, chloride, ionised calcium, glucose, lactate, haemoglobin, and carboxyhaemoglobin. The measurement comes from a single 0.5 to 1 millilitre blood sample within 1 to 2 minutes of receipt at the analyser. Ventilator management in ARDS uses serial arterial blood gas measurements to titrate the PEEP and FiO2 settings that optimise the protective lung ventilation strategy. The lactate measurement during septic shock resuscitation serves as the dynamic marker of tissue perfusion and metabolic response. The pH and bicarbonate monitoring in diabetic ketoacidosis management and these uses represent the primary critical care blood gas applications.
2. Blood Gas Analysis Market Size & Forecast
3. Emerging Technologies
- Lactate measurement in blood gas analysers has become the primary resuscitation monitoring parameter for septic shock management. The lactate clearance trajectory during the first 6 hours of treatment uses the EGDT or surviving sepsis campaign protocol. The trajectory predicts the mortality outcome and guides the intensification of the fluid and vasopressor resuscitation that the haemodynamic targets require. The initial resuscitation critically determines the outcome for septic shock patients.
- Transcutaneous blood gas monitoring uses the heated electrode sensor applied to the skin surface that measures oxygen and carbon dioxide through the skin noninvasively. The monitor provides the continuous blood gas trending that serial arterial puncture measurement cannot achieve. The benefit applies to the neonatal intensive care and paediatric anaesthesia settings where maintaining arterial access for frequent sampling is particularly challenging.
- Point-of-care blood gas testing in the operating theatre enables the immediate intraoperative assessment of ventilation adequacy, metabolic status, and electrolyte balance without specimen transport to the central laboratory. The testing reduces the intraoperative decision delay that laboratory blood gas turnaround time creates. The surgical team can manage the physiological changes that major surgery and haemorrhage produce without delay.
- Critical delta check alerting occurs when the current blood gas result differs significantly from the immediately prior result. The alert detects the preanalytical error from misidentified or mislabelled blood gas specimens that the clinical context cannot identify from the result alone. The severity of the patient's changing values versus the specimen error requires the analyser quality check. The quality check flags the clinically implausible change for the clinical team to investigate before acting on the result.
Such innovations are driving change across adjacent industries too. Discover more in our Hematology Analyzer Market.
4. Key Market Opportunity
A material opportunity in the Blood Gas Analysis market involves expanded critical care POC parameter panels integrating blood gas with electrolytes, glucose, lactate, and haemoglobin co-oximetry, where comprehensive POC critical care chemistry reduces laboratory round trips. Abbott, Radiometer, and Werfen capture this comprehensive POC critical care opportunity. Complementary growth is driven by blood gas POC expansion in lower-acuity settings. As comprehensive POC panels expand and lower-acuity settings adopt blood gas, the addressable opportunity is growing from ICU-only blood gas to broader critical care and respiratory medicine applications.
5. Top Companies in the Blood Gas Analysis Market
The following organisations hold leading positions in the Blood Gas Analysis Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Werfen
- Danaher
- Roche
- Siemens Healthineers
- Abbott
- Edan Instruments
- IDEXX Laboratories
6. Market Segmentation
The Blood Gas Analysis Market is analysed across 4 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Parameter | pHpCO2pO2ElectrolytesGlucoseLactate |
| By Setting | ICUEmergencyNeonatalOperating Room |
| By Platform | Central LabBenchtopHand-Held POC |
| By Geography | North AmericaEuropeAsia PacificLatin AmericaMiddle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Blood Gas Analysis Market trajectory over the forecast period:
Lactate Clearance Trajectory During the First 6 Hours of Septic Shock Resuscitation Has Become the Primary Blood Gas Parameter Guiding the Fluid and Vasopressor Intensification That Haemodynamic Resuscitation Targets Require.Radiometer, Instrumentation Laboratory, and Siemens Healthineers supply the blood gas analyser systems that hospitals use for the measurement of arterial pH, partial pressure of oxygen and carbon dioxide, and calculated parameters including bicarbonate and base excess that assess respiratory and metabolic acid-base status. The blood gas test panel has expanded from the core respiratory parameters to include co-oximetry measuring haemoglobin oxygen saturation, carboxyhaemoglobin, and methemoglobin alongside electrolytes and glucose metabolites that provide comprehensive critical care metabolic assessment from a single small blood sample. The blood gas analyser market is driven by the growth of critical care medicine including intensive care unit expansion, the proliferation of cardiac and vascular surgery, and the increasing acuity of emergency department patients whose respiratory management requires rapid and accurate blood gas analysis.
Transcutaneous Non-Invasive Blood Gas Monitoring Measuring O2 and CO2 Through Heated Skin Electrodes Is Enabling Continuous Trending in Neonatal ICU and Paediatric Anaesthesia Where Maintaining Arterial Access for Serial Sampling Is Particularly Challenging.SenTec's transcutaneous CO2 monitoring using a heated skin electrode and the OxyCRG combined oximetry and CO2 monitoring systems provide non-invasive continuous blood gas monitoring that complements intermittent arterial blood gas sampling in neonatal intensive care and adult ventilator management. The pulse oximetry SpO2 standard for non-invasive oxygen saturation monitoring from Masimo, Nellcor, and Nonin has been extended to include plethysmography variability index for fluid responsiveness assessment and non-invasive haemoglobin measurement that expands the information available from the standard pulse oximetry sensor. The regulatory pathway for non-invasive blood gas monitoring devices under FDA 510(k) clearance and CE marking has established the clinical performance standards that non-invasive blood gas device developers must demonstrate through clinical validation studies comparing their device output to the arterial blood gas reference standard.
Point-of-Care Intraoperative Blood Gas Testing Eliminating Specimen Transport to the Central Laboratory Is Reducing the Decision Delay That Turnaround Time Created for Surgical Teams Managing the Physiological Changes That Major Surgery and Haemorrhage Produce.The microfluidic chip design that integrates the electrochemical sensors, calibrant fluid, and waste management in a single-use cartridge eliminates the calibration and maintenance requirements of larger analysers, and the cartridge-based approach enables reliable blood gas measurement by non-laboratory personnel in challenging environments. The cold chain requirements for blood gas cartridge storage and the single-use cartridge cost represent the primary cost management challenges for handheld blood gas deployment in high-volume point-of-care settings where the per-test economics must be justified against the clinical value of rapid test turnaround.
For related market intelligence, see the In Vitro Diagnostics Market.
8. Segmental Analysis
By parameter, the pH and blood-gas metabolite segment dominated the Blood Gas Analysis Market in 2025, as Werfen GEM Premier and Radiometer ABL900 anchored critical-care arterial blood-gas measurement for ICU and emergency respiratory management, generating the dominant share of blood-gas analyser revenue.
By setting, the point-of-care and bedside segment is projected to register the highest growth rate through 2034, as Radiometer AQT90 FLEX and Abbott iSTAT Alinity extend blood-gas and lactate testing from centralised laboratory to ICU bedside, reducing result-to-treatment time in sepsis and respiratory-failure management.
9. Regional Analysis
Regional demand patterns across the Blood Gas Analysis Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America dominated the Blood Gas Analysis Market in 2025, accounting for approximately 45% of global revenue, attributed to US premium pricing for POC blood gas analysers and the large ICU and emergency department volume. Moreover, bedside POC blood gas adoption is most advanced in the US. In addition, lactate sepsis monitoring is established. Regional dominance is due to this combination of pricing environment and ICU penetration.
Highest CAGR Region
Europe is projected to register the highest CAGR in the Blood Gas Analysis Market through 2034, driven by expanding ICU and critical care infrastructure across European healthcare systems and the active European sepsis management protocol adoption integrating lactate. The region is also witnessing POC blood gas access growing. Moreover, neonatal NICU blood gas is expanding. The combination of these demand drivers and critical care expansion positions Europe for sustained growth outperformance through 2034.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology adoption trends and innovation tracking
- • Custom company profiling and benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country Trade Analysis
- • Country-level opportunity mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • List of Raw Material Suppliers
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Blood Gas Analysis Market was valued at USD 1.87 Bn in 2025 and is projected to reach USD 3.55 Bn by 2034, growing at a CAGR of 7.4% over the 2026–2034 forecast period.
The Blood Gas Analysis Market is projected to grow at a CAGR of 7.4% from 2026 to 2034.
North America dominated the Blood Gas Analysis Market in 2025, accounting for approximately 45% of global revenue, attributed to US premium pricing for POC blood gas analysers and the large ICU and emergency department volume.
The leading companies in the Blood Gas Analysis Market include Werfen, Danaher, Roche, Siemens Healthineers, Abbott, Edan Instruments, IDEXX Laboratories.
Lactate clearance trajectory during the first 6 hours of septic shock resuscitation has become the primary blood gas parameter guiding the fluid and vasopressor intensification that haemodynamic resuscitation targets require.
By parameter, the pH and blood-gas metabolite segment dominated the Blood Gas Analysis Market in 2025, as Werfen GEM Premier and Radiometer ABL900 anchored critical-care arterial blood-gas measurement for ICU and emergency respiratory management, generating the dominant share of blood-gas analyser revenue.
How to Order
Purchasing a TrendX Insights report is straightforward. Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.
This is the price of the syndicated report. Any custom inclusions beyond the Table of Contents will be scoped and priced separately. For the full list of what is covered in the syndicated report, refer to the Table of Contents tab.
A curated, condensed version of this report for students, researchers, and academic institutions. Ideal for thesis work, dissertations, and academic projects. Delivered as PDF to your institutional email.
Valid student ID or institutional email required. For educational and non-commercial use only.